Novo Nordisk's pricing techniques while in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who may have accused the company of value gouging, pointing out the stark contrast involving U.S. charges and those in Europe and copyright.Rybelsus and copyright prompted thyroid tumors in mice and rats all through animal experiments